Affida Express is a nonsteroidal anti-inflammatory and antirheumatic agent for the symptomatic treatment of mild to moderate pain of various origins (headache, toothache, painful menstruation), including colds and fever.
Warehouse
1 soft capsule contains 200 mg of ibuprofen; excipients: polyethylene glycol 600, potassium hydroxide (85% purity), purified water; capsule composition: gelatin, partially dehydrated liquid sorbitol (E 420), purified water, soy lecithin, medium chain triglycerides.
Contraindication
Hypersensitivity to the active substance or to any of the components of the medicinal product.
Hypersensitivity reactions (e.g. bronchial asthma, rhinitis, angioedema or urticaria) previously observed after the use of ibuprofen, acetylsalicylic acid or other NSAIDs.
Gastric ulcer/bleeding in active form or history of recurrence (two or more severe episodes of ulcer or bleeding).
History of gastrointestinal bleeding or perforation associated with NSAID use.
Severe hepatic impairment, severe renal impairment; heart failure (NYHA class IV).
The last trimester of pregnancy.
Method of application
Adults and children weighing ≥ 40 kg: The recommended initial dose is 1–2 capsules. If necessary, 1–2 capsules (200–400 mg ibuprofen) can be used every 4–6 hours. Do not use more than 6 capsules (1200 mg) in 24 hours.
Children weighing ≤ 39 kg. The drug can be used in children weighing at least 20 kg. The maximum daily dose of ibuprofen is 20–30 mg per kilogram of body weight, divided into 3–4 doses with an interval of 6–8 hours. Do not exceed the maximum permissible daily dose.
For children weighing 20 to 29 kg: the recommended starting dose is 1 capsule (200 mg ibuprofen). The maximum daily dose is 3 capsules (600 mg ibuprofen).
For children weighing 30 to 39 kg: the recommended starting dose is 1 capsule (200 mg ibuprofen). The maximum daily dose is 4 capsules (800 mg ibuprofen).
Application features
Ibuprofen may temporarily inhibit platelet function (affect platelet aggregation), so it is recommended to carefully monitor the condition of patients with blood clotting disorders.
With long-term use of the drug, it is necessary to regularly check liver and kidney function indicators, as well as check the blood picture.
Pregnant women
NSAIDs should not be taken during the first two trimesters of pregnancy unless, in the opinion of the physician, the potential benefit to the patient outweighs the potential risk to the fetus.
It is contraindicated to take during the last trimester of pregnancy.
Children
Do not use in children weighing < 20 kg.
Drivers
When used in accordance with the recommended doses and duration of treatment, the drug does not affect the reaction speed when driving or working with other mechanisms.
Overdose
Most patients who have taken clinically significant amounts of NSAIDs have experienced only nausea, vomiting, epigastric pain, and very rarely diarrhea. Tinnitus, headache, and gastrointestinal bleeding may also occur. In more severe poisoning, toxic CNS effects may occur, manifesting as vertigo, drowsiness, and sometimes agitation and disorientation or coma. Sometimes patients experience convulsions.
Side effects
Psychiatric disorders: psychotic reactions, depression.
Nervous system: headache, dizziness, insomnia, anxiety, irritability or fatigue.
On the part of the organs of vision: visual impairment.
From the organs of hearing and balance: tinnitus, hearing loss.
From the side of the cardiac system: palpitations, heart failure and myocardial infarction.
From the vascular system: arterial hypertension, vasculitis, edema.
Storage conditions
Store at a temperature not exceeding 30°C. Store in the original packaging. Keep out of the reach of children.
